Clinigen
Clinigen announces executive appointments to drive growth and investor value
May 1, 2025Business Services, Pharmaceutical Consultancy Services Clinigen, Keith Bryne, Nihad Hasagic, Pharma services, Pharmacy, appointment
Clinigen, the global pharmaceutical services group, has announced key leadership changes to accelerate its growth and strengthen its position in …
Clinigen becomes sole license holder of cancer drug Proleukin in $210m deal
February 14, 2019Sales and Marketing Clinigen, Novartis, Proleukin, pharma
Novartis has arranged to sell the remainder of its rights to its skin and lung cancer drug Proleukin (aldesleukin, recombinant …
Clinigen shares soar after $210m Novartis cancer drug deal
February 13, 2019Research and Development Cancer, Clinigen, Novartis, Proleukin, UK, US, oncology
British company Clinigen has bought the rights to sell Novartis’ cancer drug Proleukin in the United States in a deal …
Eisai & Clinigen to bring breast cancer drug to South Africa
December 1, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Clinigen, Eisai, South Africa, breast cancer
Eisai and Clinigen have formed a collaboration to deliver the former’s cancer treatment Halaven (eribulin) to women in South Africa …
Clinigen launches UK managed access program for Takeda’s ixazomib
November 30, 2015Sales and Marketing Clinigen, Takeda, ixazomib, managed access, multiple myeloma, oncology
Clinigen and Takeda have struck a deal to allow patients in the UK to access the multiple myeloma drug ixazomib …
Clinigen buys Idis for £225 million
April 24, 2015Sales and Marketing CBPE Capital, Clinigen, IDIS, unlicensed
UK speciality pharma group Clinigen is paying £225 million to acquire the Surrey-based unlicensed supplier of medicines firm Idis. Unlicensed …
Clinigen chief executive joins Ergomed board
May 28, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Clinigen, ergomed, george
UK drug development
 services firm Ergomed has appointed Peter George to its
board as a non-executive director.

 George has over 20 …
Dominic Atkins joins Clinigen GAP in senior commercial role
January 14, 2013Manufacturing and Production, Research and Development, Sales and Marketing Clinigen, Dominic Atkins
Pharma services company Clinigen Global Access Programs (Clinigen GAP) has appointed Dominic Atkins as global business development director. In this …
Chief operating officer appointed to Clinigen’s services division
January 19, 2012Business Services, Medical Communications, Research and Development, Sales and Marketing Clinigen, Shaun Chilton
Clinigen Group, a global specialty pharma services and products business, has appointed Shaun Chilton as its new chief operating officer …
